HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

• Click on your picture/name in Zoom
• Click on rename
• enter <name> - <organization>

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from the previous meeting

• 2023-03-06 Meeting Notes  - accepted by acclimation

Project Proposals

Project Proposals in Review - None to review

Project Scope Statements

Project Scope Statements 

• Adverse Event Clinical Research Implementation Guide
  • pharmacy is an interested party, but not sponsor or cosponsor

May WGM Draft Agenda Review

• 13 Mar 2023 - skipped

External Meeting Review

• 13 Mar 2023 - nothing to report

Catalog Updates (John Hatem)

• 13 Mar 2023 - No meeting last week

Workflow Update (John Hatem)

• 13 Mar 2023  - No update

Healthcare Product Update (John Hatem)

• 13 Mar 2023 - No update

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)

• 13 Mar 2023- No meeting this week, next meeting will be the first week of April. 

Project updates

Pharmacy Templates

• 13 Mar 2023 - Georgio has a Publication request document.  It will be discussed and voted on in the March 20th meeting. 

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

• 13 Mar 2023 - in good shape.  a number of things require input/work from other groups.  remaining items are minor 

Status state diagram review 

• John reviewed the mapping between Med dispense status and BDP dispense status.  Suggestion was to send this to the list serve for input. 
  • 13 Feb 2023 review of mapping document.  
    
    • "ready for pickup" (in pharmacy) compares to "allocated" in BDP.
      • BDP "allocated" description is "ready for transport"   
    • "returned" - we don't have it, do we need it (returned after picked up).  usually these are wasted ... but can be reused in some cases. 
      • as opposed to "return to stock," which was "ready for pickup" and not received by patient.
    • pharmacy "completed" - BDP says "issued"
    • pharmacy "stopped" ("failed") - BDP uses "unfulfilled".
    • pharmacy "declined" ("not-done) - maybe BDP "returned" ("abandoned")
  • 13 Mar 2023 - Need status update? 
    • John's working on it

Timing questions (Jose)

13 Mar 2023 - 

NCPDP Updates (NCPDP Members)

13 Mar 2023 - 

Pharmacist Consult Note (Scott)

• 13 Mar 2023 - as of last week conf call on March 6, the publication request has been submitted
  • needs minor clarifications as requested by TSC - Have these been clarified?  - YES
  • Published!  http://www.hl7.org/implement/standards/product_brief.cfm?product_id=612

Specialty Medication Enrolment IG

• 13 Mar 2023 - Need status update - have all items below been completed? 
  • STU2 Publication Request - Specialty Medication Enrollment
    • current version expires June 6, 2023
    • needs to be reviewed by FHIR Management Group
    • need to post the ballot comments spreadsheet and request withdrawal of negatives - Scott has submitted
      • https://jira.hl7.org/secure/attachment/23621/reconciliation.xls
    • Frank should be the publishing facilitator
    • #39 - should be yes
    • Provide Lynn the updated Product Brief
    • Motion to approve the publication request subject to action items above - Melva Peters - Frank McKinney - 8-0-0 Carried
    • Frank will update and forward to FMG
  • Frank reports in progress

Any Other Business

• USCDI - Shelly Spiro
  • Quick review of USCDI V4 - adding Medication Instructions and Adherence
  • Possible to add more from the Level 2 medication list
  • question is which, if any, of the Level 2 terms be added to V4.  discussed
    • Negation Reason - probably good to include
    • Medication Administration - 
    • need more info, 
  • book time next week for further discussion, invite Hans (for HITAC).  also invite Margaret (for NCPDP side).  send note to list. -Scott
• Email from Floyd - pharmacy SIG questions
  • will respond to Floyd - ask him to submit a Jira issue with specific examples and the value set that is being used
  • https://childrens.health.qld.gov.au/wp-content/uploads/PDF/digital-future/qrg/Medication-scheduling-administration-times.pdf
  • 13 Mar 2023 John responded to Floyd this morning. added supplement from our discussion
•  IHE work items (Jose) - 13 Mar 2023 - any updates needed to the items below?  Can they be removed from Agenda?  
  • IHE Pharmacy met - a couple of work items
    • produce profiles for prescription in FHIR - these would be IHE profiles
  • Unicom - identification of medications cross borders
    • querying of product based information
    • use of product information - either medication knowledge or medication definition
  • Medication Overview - medication lists in IHE

Next meeting:

• 20 Mar 2023